Compare PINS & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PINS | DVA |
|---|---|---|
| Founded | 2008 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.0B |
| IPO Year | 2019 | 2002 |
| Metric | PINS | DVA |
|---|---|---|
| Price | $17.99 | $151.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 29 | 4 |
| Target Price | $27.19 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 13.8M | 644.6K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.61 | ★ 9.84 |
| Revenue | $4,221,767,000.00 | ★ $13,643,069,000.00 |
| Revenue This Year | $14.76 | $3.85 |
| Revenue Next Year | $12.32 | $3.07 |
| P/E Ratio | $29.57 | ★ $15.43 |
| Revenue Growth | ★ 15.79 | 6.46 |
| 52 Week Low | $13.84 | $101.00 |
| 52 Week High | $39.93 | $159.42 |
| Indicator | PINS | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 53.80 |
| Support Level | $17.67 | $145.62 |
| Resistance Level | $19.23 | $152.31 |
| Average True Range (ATR) | 0.64 | 3.59 |
| MACD | 0.02 | -0.65 |
| Stochastic Oscillator | 42.60 | 57.09 |
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.